These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3533403)

  • 1. Pharmacologic aspects of lung cancer chemotherapy.
    Beard DB; Haskell CM
    Clin Chest Med; 1986 Sep; 7(3):505-13. PubMed ID: 3533403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
    Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug interactions with anticancer agents].
    Furue H
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2231-6. PubMed ID: 3907502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review.
    Marsh JC
    Cancer Res; 1976 Jun; 36(6):1853-82. PubMed ID: 773531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
    Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
    Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etoposide in the treatment of small-cell lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current clinical status of new anticancer drugs].
    Ogawa M
    Gan No Rinsho; 1983 Aug; 29(10):1049-52. PubMed ID: 6415310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of small cell lung cancer].
    Komiya T; Takada M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic aspects of cancer chemotherapy.
    Haskell CM
    Annu Rev Pharmacol Toxicol; 1977; 17():179-95. PubMed ID: 326163
    [No Abstract]   [Full Text] [Related]  

  • 11. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
    Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
    Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cytostatics on aggregation and adenine nucleotides of platelets.
    Wand H; Rieche K
    Acta Univ Carol Med Monogr; 1972; 53():275-80. PubMed ID: 4133932
    [No Abstract]   [Full Text] [Related]  

  • 13. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
    Urban T; Chastang C; Lebas FX; Duhamel JP; Adam G; Darse J; Bréchot JM; Lebeau B
    Cancer; 1999 Dec; 86(11):2238-45. PubMed ID: 10590363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of esophageal cancer].
    Fodor M; Gainza V; Csendes A
    Rev Med Chil; 1984 Nov; 112(11):1142-5. PubMed ID: 6085656
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR; Fuks JZ; Ettinger DS; Chang AY; Ruckdeschel JC; Phan SC; Blum RH
    Cancer J Sci Am; 2000; 6(1):34-9. PubMed ID: 10696737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of chemotherapy on the morphology of solid tumours.
    Cooper EH
    Schweiz Med Wochenschr; 1974 Feb; 104(8):275-8. PubMed ID: 4814679
    [No Abstract]   [Full Text] [Related]  

  • 17. Palliative therapy: extensive small cell lung cancer.
    Loehrer PJ
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):40-4. PubMed ID: 7537903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
    Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
    Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.
    Georgoulias V; Misset JL; Ribaud P; Machover D; De Vassal F; Dorval T; Musset M; Schwarzenberg L; Reizenstein P; Mathe G; Gaget H
    Anticancer Res; 1983; 3(2):107-10. PubMed ID: 6189445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.